Nontuberculous mycobacteria: I: Multicenter prevalence study in cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 167, Issue 6, 2003, Pages 828-834

  Olivier, Kenneth N ^a   Weber, David J ^b   Wallace Jr , Richard J ^b   Faiz, Ali R ^b   Lee, Ji Hyun ^b   Zhang, Yansheng ^b   Brown Elliot, Barbara A ^b   Handler, Allison ^b   Wilson, Rebecca W ^b   Schechter, Michael S ^b   Edwards, Lloyd J ^b   Chakraborti, Subha ^b   Knowles, Michael R ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b NONE

Author keywords

Cystic fibrosis; Mycobacterium abscessus; Mycobacterium avium intracellulare; Mycobacterium infections; Nontuberculous mycobacteria

Indexed keywords

ADULT; AGE; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL FEATURE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; MULTICENTER STUDY; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SPUTUM; STAPHYLOCOCCUS AUREUS; ADOLESCENT; AGE DISTRIBUTION; AGED; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIUM IDENTIFICATION; CASE CONTROL STUDY; CHILD; CLASSIFICATION; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; GENETICS; GRAM NEGATIVE INFECTION; HEALTH SURVEY; MICROBIOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING; STAPHYLOCOCCUS INFECTION; STATISTICAL MODEL; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; BACTERIAL TYPING TECHNIQUES; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RISK FACTORS; SPUTUM; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 0037445273     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200207-678OC     Document Type: Article

References (57)

1. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med 1996;154:1229-1256.
2. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9.
3. Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 1996;335:179-188.
4. Burns JL, Emerson J, Stapp JR, Yim DL, Krzewinski J, Louden L, Ramsey BW, Clausen CR. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 1998;27:158-163.
5. Burns JL, Saiman L. Burkholderia cepacia infections in cystic fibrosis. Pediatr Infect Dis J 1999;18:155-156.
6. Olivier KN, Yankaskas JR, Knowles MR. Nontuberculous mycobacterial pulmonary disease in cystic fibrosis. Semin Respir Infect 1996;11:272-284.
7. Rosenzweig DY. Pulmonary mycobacterial infections due to Mycobacterium intracellulare - avium complex: clinical features and course in 100 consecutive cases. Chest 1979;75:115-119.
8. Contreras MA, Cheung OT, Sanders DE, Goldstein RS. Pulmonary infection with nontuberculous mycobacteria. Am Rev Respir Dis 1988;137:149-152.
9. O'Brien RJ, Geiter LJ. Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States. Am Rev Respir Dis 1987;135:1007-1014.
10. Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, Figueroa WG, Fish JE. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989;321:863-868.
11. Iseman MD. Mycobacterium avium complex and the normal host: the other side of the coin. N Engl J Med 1989;321:896-898.
12. Teirstein AS, Damsker B, Kirschner PA, Krellenstein DJ, Robinson B, Chuang MT. Pulmonary infection with Mycobacterium avium-intracellulare: diagnosis, clinical patterns, treatment. Mt Sinai J Med 1990;57:209-215.
13. Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease: incidence, presentation, and response to therapy in a community setting. Am Rev Respir Dis 1991;143:1381-1385.
14. Iseman MD, Buschman DL, Ackerson LM. Pectus excavatum and scoliosis: thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 1991;144:914-916.
15. Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern: the Lady Windermere syndrome. Chest 1992;101:1605-1609.
16. Cox JN, Brenner ER, Bryan CS. Changing patterns of mycobacterial disease at a teaching community hospital. Infect Control Hosp Epidemiol 1994;15:513-515.
17. Kennedy TP, Weber DJ. Nontuberculous mycobacteria: an underappreciated cause of geriatric lung disease. Am J Respir Crit Care Med 1994;149:1654-1658.
18. Fergie JE, Milligan TW, Henderson BM, Stafford WW. Intrathoracic Mycobacterium avium complex infection in immunocompetent children: case report and review. Clin Infect Dis 1997;24:250-253.
19. Embil J, Warren P, Yakrus M, Stark R, Corne S, Forrest D, Hershfield E. Pulmonary illness associated with exposure to Mycobacterium-avium complex in hot tub water: hypersensitivity pneumonitis or infection? Chest 1997;111:813-816.
20. Huang JH, Kao PN, Adi V, Ruoss SJ. Mycobacteriam avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. Chest 1999;115:1033-1040.
21. Hjelte L, Petrini B, Kaellenius G, Strandvik B. Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax 1990;45:397-400.
22. Mulherin D, Coffey MJ, Halloran DO, Keogan MT, FitzGerald MX. Skin reactivity to atypical mycobacteria in cystic fibrosis. Respir Med 1990;84:273-276.
23. Kilby JM, Gilligan PH, Yankaskas JR, Highsmith WE Jr, Edwards LJ, Knowles MR. Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest 1992;102:70-75.
24. Aitken ML, Burke W, McDonald G, Wallis C, Ramsey B, Nolan C. Nontuberculous mycobacterial disease in adult cystic fibrosis patients. Chest 1993;103:1096-1099.
25. Hjelt K, Hojlyng N, Howitz P, Illum N, Munk E, Valerius NH, Fursted K, Hansen KN, Heltberg I, Koch C. The role of Mycobacteria Other Than Tuberculosis (MOTT) in patients with cystic fibrosis. Scand J Infect Dis 1994;26:569-576.
26. Tomashefski JF Jr, Stern RC, Demko CA, Doershuk CF. Nontuberculous mycobacteria in cystic fibrosis: an autopsy study. Am J Respir Crit Care Med 1996;154:523-528.
27. Fauroux B, Delaisi B, Clement A, Saizou C, Moissenet D. Truffot-Pernot C, Tournier G, Vu TH. Mycobacterial lung disease in cystic fibrosis: a prospective study. Pediatr Infect Dis J 1997;16:354-358.
28. Wallace RJ Jr, Brown BA, Griffith DE. Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol 1998;52:453-490.
29. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement: Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998;132:589-595.
30. Whittier S, Olivier K, Gilligan P, Knowles M, Della-Latta P. Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients: the Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. J Clin Microbiol 1997;35:2706-2708.
31. Metchock BG, Nolte FS, Wallace RJ Jr. Mycobacterium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. Washington, DC ASM Press; 1999. p. 399-437.
32. Whittier S, Hopfer RL, Knowles MR, Gilligan PH, Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 1993;31:861-864.
33. Telenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993;31:175-178.
34. Steingrube VA, Gibson JL, Brown BA, Zhang Y, Wilson RW, Rajagopalan M, Wallace RJ Jr. PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J Clin Microbiol 1995;33:149-153. [Published erratum appears in J Clin Microbiol 33:1686.]
35. Cousins D, Francis B, Dawson D. Multiplex PCR provides a low-cost alternative to DNA probe methods for rapid identification of Mycobacterium avium and Mycobacterium intracellulare. J Clin Microbiol 1996;34:2331-2333.
36. Wallace RJ Jr, Zhang Y, Brown BA, Dawson D, Murphy DT, Wilson R, Griffith DE. Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis. Am J Respir Crit Care Med 1998;158:1235-1244.
37. Wallace RJ Jr, Zhang Y, Brown BA, Fraser V, Mazurek GH, Maloney S. DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. J Clin Microbiol 1993;31:2697-2701.
38. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.
39. Zhang Y, Rajagopalan M, Brown BA, Wallace RJ Jr. Randomly amplified polymorphic DNA PCR for comparison of Mycobacterium abscessus strains from nosocomial outbreaks. J Clin Microbiol 1997;35:3132-3139.
40. Mazurek GH, Hartman S, Zhang Y, Brown BA, Hector JS, Murphy D, Wallace RJ Jr. Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool. J Clin Microbiol 1993;31:390-394.
41. Wilschanski M, Zielenski J, Markiewicz D, Tsui LC, Corey M, Levison H, Durie PR. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr 1995;127:705-710.
42. Kristidis P, Bozon D, Corey M, Markiewicz D, Rommens J, Tsui L-C, Durie P. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 1992;50:1178-1184.
43. Shetty PS, Soares MJ, James WP. Body mass index: its relationship to basal metabolic rates and energy requirements. Eur J Clin Nutr 1994;48:S28-S37.
44. Wallace RJ Jr, Glassroth J, Griffith DE, Olivier KN, Cook JL, Gordin F. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:S1-S25.
45. Schechter MS, Shelton BJ, Margolis PA, FitzSimmons SC. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med 2001;163:1331-1337.
46. Bloch KC, Zwerling L, Pletcher MJ, Hahn JA, Gerberding JL, Ostroff SM, Vugia DJ, Reingold AL. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med 1998;129:698-704.
47. Stokes ME, Davis CS, Koch GG. Categorical data analysis using the SAS system. Cary, NC: SAS Institute; 1995.
48. Tanaka E, Amitani R, Nimi A, Suzuki K, Murayama T, Kuze F. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1997;155:2041-2046.
49. Fujita J, Ohtsuki Y, Suemitsu I, Shigeto E, Yamadori I, Obayashi Y, Miyawaki H, Dobashi N, Matsushima T, Takahara J. Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex disease. Eur Respir J 1999;13:535-540.
50. Gilligan PH. Microbiology of cystic fibrosis lung disease. In: Yankaskas JR, Knowles MR, editors. Cystic fibrosis in adults. Philadelphia, PA: Lippincott-Raven Publishers; 1999. p. 93-114.
51. Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969;99:S1-S132.
52. Good RC, Snider DE Jr. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 1982;146:829-833.
53. Butler WR, Crawford JT, Shutt K. Nontuberculous mycobacteria reported to the public health laboratory information system by state public health laboratories, United States, 1993-1996. 1999. http://www. cdc.gov/ncidod/dastlr/TB/ntmfinal.pdf: National Center for Infectious Diseases, CDC&P. Accessed on January 15, 2003.
54. Tanaka E, Kimoto T, Tsuyuguchi K, Watanabe I, Matsumoto H, Niimi A, Suzuki K, Murayama T, Amitani R, Kuze F. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1999;160:866-872.
55. Maesaki S, Kohno S, Koga H, Miyazaki Y, Kaku M. A clinical comparison between Mycobacterium avium and Mycobacterium intracellulare infections. Chest 1993;104:1408-1411.
56. Tanaka E, Amitani R, Murayama T, Suzuki K, Niimi A, Kuze F. Computed tomography diagnosis of Mycobacterium avium complex lung disease: prospective study. [abstract]. Am J Respir Crit Care Med 1995;151:A476.
57. Olivier KN, Weber DJ, Lee JH, Handler A, Tudor G, Molina PL, Tomashefski J, Knowles MR, for the Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Nontuberculous mycobacteria. II: Nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med 2003;167:835-840.